EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The therapeutic effects of vonoprazan against giardiasis in rats: parasitological, pathological, and immunological aspects

Alaa F Sallam, Kholoud A El-Nouby, Hend S Abo Safia, Dina I Elgendy

Parasitology Research · 2025

DOI: 10.1007/s00436-025-08526-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Parasitology Research, 2025. Verfasst von Alaa F Sallam und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical Parasitology Department, Faculty of Medicine, Tanta University, Tanta, Egypt. Hauptthemen laut MEDLINE: Giardiasis, Pyrroles, Sulfonamides, Antiprotozoal Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Giardiasis is a serious public health issue caused by Giardia lamblia. The medications used in its treatment induce unfavorable adverse effects. Furthermore, treatment failure and drug resistance are other challenges in its management. Vonoprazan is a safe, recently approved potassium-competitive acid blocker. The current study aimed to assess the potential therapeutic effects of vonoprazan, alone or in combination with metronidazole, on giardiasis. The efficiency of the treatment was evaluated by parasitological, histopathological, immunohistochemical, scanning electron microscopic, and biochemical studies. According to the results, the combination treatment significantly reduced the number of cysts in the stool and trophozoites in the small intestinal wash and ameliorated the intestinal pathological alterations. The expression of TNF-α and caspase-3 in the intestinal tissues was reduced. Also, there were reductions in the levels of IL-6, iNO, and MAD and an elevation in TAC levels in the serum. The combination therapy exhibited better efficacy than metronidazole alone. To sum up, this study underlines the suitability of using vonoprazan as an adjuvant to metronidazole in treating giardiasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GiardiasisPyrrolesSulfonamidesAntiprotozoal AgentsGiardia lambliaAnimalsMetronidazoleRatsDrug Therapy, CombinationMaleDisease Models, AnimalFecesTreatment Outcome

Stichwörter der Autor:innen

Giardia lambliaCaspase-3IL-6INOMADScanning electron microscopyTACTNF-αVonoprazan

Substanzen

PyrrolesSulfonamides1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamineMetronidazoleAntiprotozoal Agents

Autor:innen und Institutionen

  • Medical Parasitology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
  • Pathology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
  • Basic Medical Sciences Department, Faculty of Medicine, Ibn Sina University for Medical Sciences, Amman, 16197, Jordan.
  • Medical Parasitology Department, Faculty of Medicine, Tanta University, Tanta, Egypt. dina.elgendy@med.tanta.edu.eg.

Zitieren

APA

Sallam, A. F., El-Nouby, K. A., Safia, H. S. A., & Elgendy, D. I. (2025). The therapeutic effects of vonoprazan against giardiasis in rats: parasitological, pathological, and immunological aspects. Parasitology Research. https://doi.org/10.1007/s00436-025-08526-9

Vancouver

Sallam AF, El-Nouby KA, Safia HSA, Elgendy DI. The therapeutic effects of vonoprazan against giardiasis in rats: parasitological, pathological, and immunological aspects. Parasitology Research. 2025. doi:10.1007/s00436-025-08526-9

BibTeX
@article{Sallam2025,
  author = {Sallam, Alaa F and El-Nouby, Kholoud A and Safia, Hend S Abo and Elgendy, Dina I},
  title = {The therapeutic effects of vonoprazan against giardiasis in rats: parasitological, pathological, and immunological aspects},
  journal = {Parasitology Research},
  year = {2025},
  doi = {10.1007/s00436-025-08526-9}
}
Kostenlos starten →